Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-01 Sale | 2024-03-04 8:39 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,000 | $57.5 | $115,000 | 50,110 (Direct) | View |
| 2023-07-27 Sale | 2023-07-28 4:06 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,000 | $97.42 | $194,840 | 52,110 (Direct) | View |
| 2023-06-09 Sale | 2023-06-12 4:29 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 1,402 | $90.51 | $126,895 | 54,110 (Direct) | View |
| 2023-05-26 Sale | 2023-05-31 4:13 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,000 | $80.62 | $161,240 | 51,913 (Direct) | View |
| 2021-07-30 Sale(A) | 2021-08-03 1:01 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,640 | $111.17 | $293,489 | 29,830 (Direct) | View |
| 2021-07-30 Sale | 2021-08-02 4:42 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,640 | $111.17 | $293,489 | 29,830 (Direct) | View |
| 2021-02-26 Sale | 2021-03-02 6:57 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,000 | $130.11 | $260,220 | 30,459 (Direct) | View |
| 2020-07-31 Sale | 2020-08-04 4:45 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,539 | $94 | $238,666 | 32,459 (Direct) | View |
| 2020-02-28 Sale | 2020-03-03 7:20 pm | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,000 | $77.54 | $155,080 | 32,440 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-13 Option Award(A) | 2024-12-20 4:30 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 5,939 | $0 | 56,049 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 5:30 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 5,444 | $0 | 55,554 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:29 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 3,599 | $0 | 54,110 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-18 4:09 pm | N/A 2024-07-24 | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 5,477 | $0 | 53,913 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-18 4:09 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 5,477 | $16.52 | 53,913 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:24 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 5,606 | $0 | 48,436 (Direct) | View |
| 2022-06-07 Exercise | 2022-06-08 4:02 pm | N/A 2024-07-24 | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 3,000 | $0 | 48,307 (Direct) | View |
| 2022-06-07 Exercise | 2022-06-08 4:02 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 3,000 | $16.52 | 48,307 (Direct) | View |
| 2022-03-17 Exercise | 2022-03-18 4:24 pm | N/A 2024-07-24 | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 10,000 | $0 | 48,307 (Direct) | View |
| 2022-03-17 Exercise | 2022-03-18 4:24 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 10,000 | $16.52 | 48,307 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 4:01 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,011 | $0 | 32,470 (Direct) | View |
| 2020-07-23 Option Award | 2020-07-24 4:30 pm | N/A N/A | EXACT SCIENCES CORP | EXAS | Doyle James Edward Director | 2,558 | $0 | 34,998 (Direct) | View |